[go: up one dir, main page]

ZA200704286B - Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation - Google Patents

Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation

Info

Publication number
ZA200704286B
ZA200704286B ZA200704286A ZA200704286A ZA200704286B ZA 200704286 B ZA200704286 B ZA 200704286B ZA 200704286 A ZA200704286 A ZA 200704286A ZA 200704286 A ZA200704286 A ZA 200704286A ZA 200704286 B ZA200704286 B ZA 200704286B
Authority
ZA
South Africa
Prior art keywords
preparation
phytosterol
diglyceride
delivery
metal cations
Prior art date
Application number
ZA200704286A
Inventor
Maurel Jean-Claude
Original Assignee
Medesis Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medesis Pharma filed Critical Medesis Pharma
Publication of ZA200704286B publication Critical patent/ZA200704286B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)

Abstract

The present invention relates to a method for the preparation of reverse micelles based on sterols, acylglycerols and metal salt and to reverse micelles obtained thereby. They are advantageously useful in the pharmaceutical and dietetic fields.
ZA200704286A 2004-11-02 2007-05-25 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation ZA200704286B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04025987A EP1652512A1 (en) 2004-11-02 2004-11-02 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation

Publications (1)

Publication Number Publication Date
ZA200704286B true ZA200704286B (en) 2008-09-25

Family

ID=34927200

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200704286A ZA200704286B (en) 2004-11-02 2007-05-25 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation

Country Status (16)

Country Link
US (1) US9173838B2 (en)
EP (2) EP1652512A1 (en)
JP (1) JP4975631B2 (en)
CN (1) CN101102751B (en)
AT (1) ATE483454T1 (en)
AU (1) AU2005300253B2 (en)
CA (1) CA2584684C (en)
DE (1) DE602005024036D1 (en)
DK (1) DK1807048T3 (en)
EA (1) EA012210B1 (en)
ES (1) ES2353804T3 (en)
IL (1) IL182756A (en)
PL (1) PL1807048T3 (en)
PT (1) PT1807048E (en)
WO (1) WO2006048773A1 (en)
ZA (1) ZA200704286B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1652513A1 (en) * 2004-11-02 2006-05-03 Denderah Pharm Sa Reverse micelles based on sterols and acylglycerols and therapeutic uses thereof
WO2011117333A2 (en) 2010-03-24 2011-09-29 Medesis Pharma Reverse micelle system comprising metal ions and use thereof
BRPI1000970A2 (en) * 2010-04-07 2011-11-29 Fundacao Arnaldo Vieira De Carvalho pharmaceutical composition for the treatment of Alzheimer's disease, process for its obtaining and use
WO2012007387A1 (en) * 2010-07-13 2012-01-19 Medesis Pharma Low- dose lithium for the treatment of neurodegenerative disorders
EP3319588A1 (en) * 2015-07-09 2018-05-16 Medesis Pharma In situ preparation of cyano-bridged metal nanop articles within a biocompatible reverse micellar system
CA3103704A1 (en) * 2018-07-06 2020-01-09 Medesis Pharma Reverse micelle system for treatment and prevention of injury due to radiation exposure
WO2024184369A1 (en) * 2023-03-06 2024-09-12 Medesis Pharma Formulation for the buccal administration of a biocompatible reverse micelle system

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252333A (en) * 1987-04-27 1993-10-12 Scotia Holdings Plc Lithium salt-containing pharmaceutical compositions
FR2658816A1 (en) * 1990-02-27 1991-08-30 Adir NOVEL ALKALINOTERREUX METAL SALTS OF OXA-POLYACIDS, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2729957B1 (en) * 1995-01-31 1997-12-05 Maurel Sante ORGANOMETALLIC COMPLEXES BASED ON SITOSTEROLS AND ACYLGLYCEROLS AND PHARMACEUTICAL COMPOSITIONS AND DIETETIC PRODUCTS CONTAINING SAME.
FR2750606B1 (en) * 1996-07-03 1999-01-29 Maurel Sante ORGANOMETALLIC COMPLEXES BASED ON SITOSTEROLS AND DIGLYCERIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
JPH119988A (en) * 1997-06-26 1999-01-19 Advanced Sukin Res Kenkyusho:Kk Water-in-oil microemulsion
JPH1129464A (en) * 1997-07-07 1999-02-02 Advanced Sukin Res Kenkyusho:Kk Water-in-oil microemulsion with cholesterol
WO2000057721A2 (en) * 1999-03-26 2000-10-05 Akesis Pharmaceuticals, Inc. Edible solids for treatment of glucose metabolism disorders
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
US6365176B1 (en) * 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
HUP0303021A3 (en) * 2001-01-25 2005-09-28 Unilever Nv Microemulsions
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
EP1452175A1 (en) * 2003-02-28 2004-09-01 Medesis Pharma S.A. Manganese based organometallic complexes, pharmaceutical compositions and dietetic products
CN1457773A (en) * 2003-06-02 2003-11-26 乐益 Biguanide vanadium complex granular powder and/or capsule for curing diabetes and its use
EP1652513A1 (en) * 2004-11-02 2006-05-03 Denderah Pharm Sa Reverse micelles based on sterols and acylglycerols and therapeutic uses thereof

Also Published As

Publication number Publication date
PT1807048E (en) 2010-11-29
WO2006048773A1 (en) 2006-05-11
PL1807048T3 (en) 2011-03-31
IL182756A (en) 2011-02-28
EP1807048B1 (en) 2010-10-06
HK1108368A1 (en) 2008-05-09
DK1807048T3 (en) 2011-01-10
CA2584684C (en) 2013-07-02
US20090087477A1 (en) 2009-04-02
CA2584684A1 (en) 2006-05-11
AU2005300253A1 (en) 2006-05-11
EP1652512A1 (en) 2006-05-03
CN101102751A (en) 2008-01-09
DE602005024036D1 (en) 2010-11-18
IL182756A0 (en) 2007-07-24
EA012210B1 (en) 2009-08-28
EA200700994A1 (en) 2007-10-26
JP4975631B2 (en) 2012-07-11
ES2353804T3 (en) 2011-03-07
AU2005300253B2 (en) 2010-09-09
US9173838B2 (en) 2015-11-03
CN101102751B (en) 2011-08-24
ATE483454T1 (en) 2010-10-15
JP2008519026A (en) 2008-06-05
EP1807048A1 (en) 2007-07-18

Similar Documents

Publication Publication Date Title
ZA200704286B (en) Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation
WO2007110421A3 (en) Whey protein micelles
EP2462924A3 (en) Improvements in or relating to amphoteric liposomes.
WO2005067898A3 (en) Improved sustained release compositions for pulmonary administration of insulin
IL178128A0 (en) Salts of 3-0-(3',3'-dimethyl-succinyl) betulinic acid and pharmaceutical compositions containing the same
DE69906719T2 (en) Phytosterol compositions
EP1698329A4 (en) Drug-containing nanoparticle, process for producing the same and parenterally administered preparation from the nanoparticle
CA2590433A1 (en) Multi-phase personal care composition comprising visually distinct phases
EP1847180A3 (en) Protein-enriched frozen dessert
FR2934955B1 (en) ENCAPSULATION OF LIPOPHILIC OR AMPHIPHILIC THERAPEUTIC AGENTS IN NANOEMULSIONS
PL368976A1 (en) Composition for lowering blood cholesterol
WO2008036353A3 (en) Omega-3 diglyceride emulsions
WO2008063808A3 (en) Encapsulated peptide amphiphile nanostructures
WO2008042973A3 (en) Lipid containing formulations
CA2595907A1 (en) Creatine hydroxycitric acid salts and methods for their production and use in individuals
WO2008081934A1 (en) Agent for facilitating the development of brain in infant comprising milk-derived phospholipid and food composition comprising the same
WO2008011272A3 (en) Liquid monophasic lipid-soluble antioxidant compositions and processes for making the compositions
WO2012139080A3 (en) Lipid-based nanoparticles
TW200603746A (en) Iron sulfate based phosphate adsorbent
WO2008070141A3 (en) Compositions for delivery of therapeutic agents
WO2002041881A3 (en) Repinotan kit
WO2005079396A3 (en) O,o'-amidomalonate and n,o-amidomalonate platinum complexes
WO2007023476A3 (en) Compositions and methods for producing apolipoprotein gene products in lactic acid bacteria
EP1637167A3 (en) New injectable formulations containing progesterone
TW200630343A (en) 2-Alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof